While previous medications only targeted one or two pathways, Retatrutide targets the "Triple G" Pathway: GLP-1: Controls hunger and slows digestion
19,20 In the gastrointestinal tract, GLP-1RAs can activate the autonomic nervous system that regulates gastrointestinal motility to slow the movement of food from the stomach to the intestines, a process called gastric emptying
Therapeutic Goods Administration (TGA)
Many individuals notice: More significant weight loss Improved body composition Better physical endurance Greater motivation to stay consistent This is often when family members and friends begin noticing visible changes
A couple of the main ones are energy levels, metabolism support, skin health, immune system and DNA repair
The added glucagon receptor activity is studied for its distinct metabolic research profile